AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Get Alerts ABBV Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.2%
EPS Growth %: +26.6%
Join SI Premium – FREE
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media:
| Investors:
|
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302787501.html
SOURCE AbbVie
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monster Energy's Manel Kape Stops Kyoji Horiguchi at UFC Fight Night 279 in Las Vegas
- Roofing Expert Matt Waligorski of Livonia Outlines What Makes a Roofer Truly Trustworthy for HelloNation
- Father's Day Gifts Are Shifting Toward Wellness: CINCOM Encourages Families to Give Dad a Moment to Recover
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share